Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

1.1K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The response of human melanocytic nevi to simulated solar radiation assessed by single-nucleus RNA sequencing of frozen tissue.

The Journal of investigative dermatology·2026
Same author

Spectral EEG-guided adaptive neuromodulation for social anxiety disorder, performance-only subtype: a case report.

Frontiers in psychiatry·2026
Same author

Reward Deficiency Syndrome (RDS): A Common Neurogenetic Trait/State of All Addictions: Is this the new DSM?

British journal of healthcare and medical research·2026
Same author

Neurogenetics and Epigenetics of Spirituality and Religion: Seeking Genospirituality Via the Lens of Hierarchical Neuro-Spiritual Model (HNSM).

Neurology (E-Cronicon)·2026
Same author

Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.

Current pharmaceutical biotechnology·2026
Same author

Case Report: rTMS for recurrent major depressive disorder and generalized anxiety disorder comorbid with atrial fibrillation.

Frontiers in psychiatry·2026

Related Experiment Video

Updated: Feb 24, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.6K

Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).

Kenneth Blum1,2,3,4,5,6,7,8,9,10,11, Marcelo Febo1, Lyle Fried3

  • 1Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, FL, USA.

Journal of Reward Deficiency Syndrome and Addiction Science
|August 15, 2017
PubMed
Summary
This summary is machine-generated.

The opioid epidemic causes daily deaths, and current treatments offer limited long-term recovery. KB220, a novel glutaminergic-dopaminergic optimization complex, may restore dopamine homeostasis for addiction recovery.

Keywords:
MetenkephalinNeurotransmitter signalingOpioid epidemicReward cascade

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K
A Fully Automated and Highly Versatile System for Testing Multi-cognitive Functions and Recording Neuronal Activities in Rodents
09:13

A Fully Automated and Highly Versatile System for Testing Multi-cognitive Functions and Recording Neuronal Activities in Rodents

Published on: May 3, 2012

14.9K

Related Experiment Videos

Last Updated: Feb 24, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.6K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.5K
A Fully Automated and Highly Versatile System for Testing Multi-cognitive Functions and Recording Neuronal Activities in Rodents
09:13

A Fully Automated and Highly Versatile System for Testing Multi-cognitive Functions and Recording Neuronal Activities in Rodents

Published on: May 3, 2012

14.9K

Area of Science:

  • Neuroscience
  • Addiction Science
  • Pharmacology

Background:

  • The global opiate/opioid epidemic results in numerous daily overdose deaths.
  • Current Medication-Assisted Treatments (MATs) primarily block dopaminergic function or use Opiate Substitution Therapy (OST).
  • Existing MATs provide short-term symptom management but are insufficient for long-term recovery and addressing addiction's root causes.

Purpose of the Study:

  • To review the development of KB220, a glutaminergic-dopaminergic optimization complex for addiction treatment.
  • To explore KB220's potential to rebalance the brain's reward circuitry and "anti-reward systems."
  • To investigate the induction of "dopamine homeostasis" as a mechanism for addiction recovery and relapse prevention.

Main Methods:

  • This mini-review synthesizes existing literature on KB220's development and proposed mechanisms.
  • It examines the role of glutaminergic and dopaminergic transmission in addiction and reward pathways.
  • The review discusses the scientific basis for targeting these systems to achieve "dopamine homeostasis."

Main Results:

  • KB220 is a novel treatment approach targeting the glutaminergic-dopaminergic system.
  • Evidence suggests KB220 may modulate brain reward and anti-reward circuitry.
  • The potential for KB220 to induce "dopamine homeostasis" is highlighted as a key therapeutic goal.

Conclusions:

  • There is a critical need for improved, long-term addiction treatments beyond current MATs.
  • KB220 represents a promising therapeutic strategy by aiming to restore "dopamine homeostasis."
  • Further research is encouraged to validate KB220's efficacy in addiction recovery and relapse prevention.